High-pressure crystallisation has been successfully used as an alternative technique to prepare Form II of a non-steroidal anti-inflammatory drug, mefenamic acid (MA). A single crystal of Form II, denoted as high-pressure Form II, was grown at 0.3 GPa from an ethanolic solution by using a diamond anvil cell. A comparison of the crystal structures shows that the efficient packing of molecules in Form II was enabled by the structural flexibility of MA molecules. Compression studies performed on a single crystal of Form I resulted in a 14% decrease of unit cell volume up to 2.5 GPa. No phase transition was observed up to this pressure. A reconstructive phase transition is required to induce conformational changes in the structure, which was co...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, <b>MA</b>, has been know...
High-pressure crystallisation has been successfully used as an alternative technique to prepare Form...
High-pressure crystallisation has been successfully used as an alternative technique to prepare Form...
High-pressure crystallisation has been successfully used as an alternative technique to prepare Form...
The crystallization of Mefenamic Acid, (MA), which has a prevalent usage in drug formulation, was in...
The effects of high pressure on a selection of organic compounds have been studied. Crystallisation ...
Hexion Specialty Chemicals;Mitsubishi Chemical Corporation;CS Cabot;Zentiva;BorsodChem MCHZCHISA 200...
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, MA, has been known to ex...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
In this study, the polymorphic transitions of mefenamic acid (MA) were studied by synchrotron X-ray ...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, <b>MA</b>, has been know...
High-pressure crystallisation has been successfully used as an alternative technique to prepare Form...
High-pressure crystallisation has been successfully used as an alternative technique to prepare Form...
High-pressure crystallisation has been successfully used as an alternative technique to prepare Form...
The crystallization of Mefenamic Acid, (MA), which has a prevalent usage in drug formulation, was in...
The effects of high pressure on a selection of organic compounds have been studied. Crystallisation ...
Hexion Specialty Chemicals;Mitsubishi Chemical Corporation;CS Cabot;Zentiva;BorsodChem MCHZCHISA 200...
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, MA, has been known to ex...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
In this study, the polymorphic transitions of mefenamic acid (MA) were studied by synchrotron X-ray ...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
Mefenamic acid [2-(2, 3-dimethylphenyl) amino benzoic acid] is an active pharmaceutical compound tha...
For several years, the non-steroidal anti-inflammatory drug mefenamic acid, <b>MA</b>, has been know...